Alnylam Pharmaceuticals Inc. (ALNY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
No. Hedge Fund Shares Value Activity % Port
1. 7,000 $1,647 0.86%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$285.00 52,592 Officer 11,989 2025-01-27 Filing
$275.00 11,250 Director 0 2025-01-23 Filing
$255.80 1 Officer 15,705 2024-12-12 Filing
$254.37 140 Officer 15,706 2024-12-12 Filing
$252.94 100 Officer 15,846 2024-12-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 16,174,563 $3,096,023,554 0.55%
2. 11,943,895 $2,286,180,943 0.05%
3. 10,312,356 $1,973,888,016 0.15%
4. 8,521,115 $1,631,026,620 0.04%
5. 7,214,198 $1,380,869,641 0.25%
News See All